Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study

BACKGROUND: The KEYNOTE-811 study exhibited promising preliminary results for HER2-positive metastasis gastric adenocarcinoma; however, long-term survival benefit remains to be determined. METHODS: In this single-center, controlled, retrospective study, patients with histologically confirmed HER2-po...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Ting, Li, Danyang, Yang, Yuchong, Wang, Feixue, Bai, Ming, Liu, Rui, Li, Hongli, Ba, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234698/
https://www.ncbi.nlm.nih.gov/pubmed/37274273
http://dx.doi.org/10.3389/fonc.2023.1166040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234698/
https://www.ncbi.nlm.nih.gov/pubmed/37274273
http://dx.doi.org/10.3389/fonc.2023.1166040

Ejemplares similares